Guangdong Releases Second Catalogue of Hong Kong and Macao Drugs and Medical Devices for Urgent Clinical Use in the GBA
10 March 2022
Business Advisory Section, HKTDC Research
A catalogue of the second batch of imported Hong Kong- and Macao-registered drugs and medical devices for urgent clinical use in the Greater Bay Area has been released by the medical products administration and the health commission of Guangdong province. Items covered include the cancer drug Piqray (alpelisib), cell sorting and processing systems, and more.
- Medical Supplies & Medicine
- Mainland China